glp-1 blindness A potentially blinding condition is a very rare side effect of the receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Can Ozempic-like Drugs Cause Blindness?

GLP-1 receptor agonists and SGLT2 inhibitors for the treatment of type 2 diabetes: new insights and opportunities for cardiovascular protection

This remedy can be used daily to help achieve a brighter complexion and control melanin levels naturally

Ruggeri RM, Minciullo P, Saitta S, Giovinazzo S, Certo R, Campenn A, Benvenga, S

Although oral semaglutide might be a better option for patients who are allergic to injections or reluctant to self-inject, its efficacy may be limited by its stringent administration guidelines, which call for taking it half an hour before the first meal, drink, or other medication [90]

Together, these peptides might improve circulation, reduce inflammation, and speed up cellular responses that allow injured tissues to develop new structures more efficiently